All News

Sacituzumab govitecan-hziy is the first antibody-drug conjugates approved by the FDA specifically for relapsed or refractory metastatic triple-negative breast cancer (TNBC).

Implementation of adherence programs can be effective in improving outcomes for patients and reduce costs both at the patient and systemic level.

Using CRISPR technology, researchers conducted a study aimed at identifying genes that fuel leukemia growth, in order to find new vulnerabilities in chronic myeloid leukemia that can be targeted.

An analysis has shown that aspirin is associated not only with a significant reduction in the risk of developing several cancer types.

Patients with type 2 diabetes (T2D) do not secrete enough insulin and secrete too much glucagon, contributing to poor blood glucose because the glucagon-secreting α-cells have become resistant to insulin.

Today, we’re celebrating Katherine Hicks, RPh, for her work at the Community Medical Clinic of Aiken County (CMCAC) in South Carolina.

Cancer cells avoid an immune system attack after radiation by taking control of a cell signaling pathway that helps dying cells avoid triggering an immune response.

Statin therapy is known to reduce the risk of cardiovascular events, and guidelines recommend them in all patients with diabetes.

Patients with BRAF mutations administered treatment with encorafenib/binimetinib trended toward improved and longer responses than patients who received dabrafenib/trametinib.

Obesity increases the risk of developing type 2 diabetes by at least 6 times, regardless of genetic predisposition, according to a recent study.

The FDA has approved the first diagnostic test with a home collection option for the coronavirus disease 2019.

The new guidance authorizes licensed pharmacists to order and administer COVID-19 tests, including serology tests, that are approved by the FDA.

Today, we’re celebrating Hany Youssef, RPh, owner of LIFETIME Pharmacy in Allen, Texas.

A phase 3 trial evaluated nivolumab in combination with ipilimumab in patients with previously untreated MPM and successfully met its primary endpoint of overall survival.

Purdue University researchers have created technology that uses optical imaging to better help surgeons map out tumors in the body and understand how certain diseases affect activity in the brain.